Healthcare-associated infections (HAIs) are a growing concern and more emphasis is being placed on eliminating potentially deadly episodes.
The Centers for Disease Control and Prevention (CDC) define HAIs as “infections that patients acquire during the course of receiving healthcare treatment for other conditions.”
The CDC reports that medical care-related infections can be devastating and even deadly. They can also be costly for healthcare providers.
A 2009 study published by the CDC estimates that the annual direct hospital cost of treating HAIs in the United States is in the billions.
“Applying two different Consumer Price Index (CPI) adjustments to account for the rate of inflation in hospital resource prices, the overall annual direct medical costs of HAI to U.S. hospitals ranges from $28.4 to $33.8 billion (after adjusting to 2007 dollars using the CPI for all urban consumers) and $35.7 billion to $45 billion (after adjusting to 2007 dollars using the CPI for inpatient hospital services),” according to the CDC study. “After adjusting for the range of effectiveness of possible infection control interventions, the benefits of prevention range from a low of $5.7 to $6.8 billion (20 percent of infections preventable, CPI for all urban consumers) to a high of $25.0 to $31.5 billion (70 percent of infections preventable, CPI for inpatient hospital services).”
These factors help account for the growth of the global disinfectants market.
According to a report from Global Industry Analysts Inc., the market is also driven by an increased focus on hygiene and growing concerns over the spread of infectious diseases both at home and in public places. Rising demands in the food and healthcare industries will continue to drive the market. In those industries, cleaning and sanitation are vital for safety. Disinfectant chemicals are also becoming more common as an ingredient in various conventional and industrial cleaning products.
The GIA report indicated “that outbreaks of infectious diseases and epidemics, such as, Swine Flu (H1N1), Avian Influenza (Bird Flu), Pertussis, Common Flu, Cholera, and West Nile Virus Infection, among others, have made spending on cleaning and disinfectant products less discretionary and more indispensable. The role played by cleaning and disinfectant products in addressing key society and social issues related to health and well being makes the market for the same resilient to recessionary forces.”
The report says that the global disinfectants market will remain strong because sanitation and hygiene are essential. GIA says the global market will reach $2.9 billion by 2017.
Aerosol and liquid products are the most commonly used surface disinfectants, though a growing number of hospitals and healthcare facilities are implementing ultraviolet (UV) disinfection systems as an additional measure.
Promotional campaigns and a demand from developing markets, especially the Asia-Pacific region, will also help push the market to new heights.
The GIA report indicates that major players in the global disinfectants marketplace include 3M Company, Ecolab Inc., Henkel KGaA, Kao Corporation, Prestige Brands Inc., Procter & Gamble Co., Reckitt Benckiser Plc, SC Johnson & Son Inc., Sealed Air Corporation, Diversey Inc., The Clorox Company, Unilever Plc, and Zep Inc.